Call for Abstract
Scientific Program
International Congress on Neuroimmunology and Therapeutics, will be organized around the theme “Contemporary explorations in Neuroimmunology to treat human diseases”
neuroimmunology 2015 is comprised of 18 tracks and 167 sessions designed to offer comprehensive sessions that address current issues in neuroimmunology 2015.
Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.
Register now for the conference by choosing an appropriate package suitable to you.
- Track 1-1JC (John Cunningham) virus
- Track 1-2Herpesviruses
- Track 1-3Human cytomegalovirus (CMV)
- Track 1-4Varicella-zoster virus (VZV)
- Track 1-5Epstein-Barr virus (EBV)
- Track 1-6Rhabdoviruses
- Track 1-7Paramyxoviruses
- Track 1-8Retroviruses
- Track 1-9Viral-induced demyelination
- Track 1-10HIV-related neurological disease
- Track 2-1DNA methylation inhibitors
- Track 2-2HDAC inhibitors
- Track 2-3RNA-based approaches
- Track 2-4Immunoglobulin therapy for inflammatory neuropathy
- Track 2-5Seretonin Inhibitors
- Track 3-1Neuroimaging techniques
- Track 3-2Pathogenesis in cerebrospinal fluid, blood, or saliva
- Track 3-3Arterial spin labeling MRI
- Track 3-4Pharmacogenomics biomarkers in diseases
- Track 3-5Heterogeneity
- Track 3-6Genetic polymorphisms
- Track 3-7Variable expression of drug receptors
- Track 3-8Single-nucleotide polymorphisms
- Track 3-9Single-Tandem Repeats (STRs)
- Track 3-10Biomarkers and Neuroimaging in Multiple Sclerosis and Neuromyelitis Optica
- Track 4-1Molecular neuropharmacology: Neurochemical interactions and Neurological disorders and Novel drugs
- Track 4-2Current research in Behavioral neuropharmacology
- Track 4-3Computed Tomography (CT) scanning
- Track 4-4Physical therapy
- Track 4-5Speech therapy
- Track 4-6Occupational therapy
- Track 4-7Antipsychotic drugs
- Track 4-8Neuroimmunologic Response to Surgical Aggression and Anesthesia
- Track 5-1Parkinson’s and Alzheimer’s diseases
- Track 5-2Amyotrophic lateral sclerosis
- Track 5-3Therapeutic use
- Track 5-4Cerebral Palsy
- Track 5-5Alzheimer’s Disease
- Track 5-6Multiple Sclerosis
- Track 5-7Parkinson’s Disease
- Track 6-1Stress
- Track 6-2Tourette Syndrome
- Track 6-3Mood Disorders
- Track 6-4Sleep disorders
- Track 6-5Immune-Brain loop
- Track 6-6 Hypothalamic-pituitary-adrenal axis (HPA axis)
- Track 6-7 Sympathetic nervous system (SNS)
- Track 6-8Autoimmune hypersensitivity
- Track 6-9Antipsychotic drugs
- Track 6-10Corticotropin-releasing hormone (CRH)
- Track 6-11Stress management strategy
- Track 6-12Relaxation Therapies
- Track 6-13Premature Aging
- Track 6-14Psychotherapy
- Track 7-1Astrocyte activation
- Track 7-2Neuropathic pain
- Track 7-3Biomarkers
- Track 7-4MRI and Nanoparticles
- Track 7-5Advances in Molecular and Cellular Imaging of Inflammation
- Track 7-6Inflammatory Neuropathy
- Track 7-7Clinical Applications
- Track 7-8Neurodegenerative diseases
- Track 7-9Inflammatory mediators
- Track 7-10Microglial activation
- Track 7-11Neuroprotective anti-inflammatory therapeutics
- Track 8-1Degenerative disorders
- Track 8-2Alzheimer’s disease
- Track 8-3Mood disorders
- Track 8-4Schizophrenia
- Track 8-5Small fiber neuropathy
- Track 8-6Plasmapheresis
- Track 8-7Intravenous immunoglobulin
- Track 8-8Autonomic neuropathy
- Track 8-9Chronic Traumatic Encephalopathy
- Track 9-1Neuroimmunogenetics of multiple sclerosis
- Track 9-2Translational digital medicine
- Track 9-3MRI brain imaging
- Track 9-4Immunological and Genetic biomarkers
- Track 9-5SNPs associated with MS
- Track 10-1Developmental and regenerative Neurobiology
- Track 10-2Inflammatory diseases and therapeutics
- Track 10-3Atrial Fibrillation
- Track 10-4Stem cell therapy in acute Ischemic Stroke
- Track 10-5Neuroendocrine cell and current reserach
- Track 10-6Immunopathogenesis of progressive multifocal Leukoencephalopathy (PML)
- Track 10-7Immune response
- Track 10-8Neuroimmunology and Brain Tumor
- Track 10-9Neuroimmunomodulation
- Track 10-10Epigenetics of Neuroimmunology
- Track 10-11Pathogenesis of Immune-mediated Neurological Disorders
- Track 10-12Immunopathogenesis of Paraneoplastic Neurologic Syndrome
- Track 11-1Meningitis
- Track 11-2Brain Abscess
- Track 11-3Epilepsy
- Track 11-4Central Nervous system
- Track 11-5Multiple sclerosis
- Track 11-6Neuromyelitis Optica
- Track 11-7Late-stage Neurological Trypanosomiasis
- Track 11-8Progressive Multifocal Leukoencephalopathy (PML)
- Track 11-9De Vivo disease
- Track 12-1Parkinsons diseases
- Track 12-2Huntingtons diseases
- Track 12-3Fronto-temporal lobe dementia (FTLD)
- Track 12-4Amyotrophic lateral sclerosis (ALS)
- Track 12-5Prion diseases (Creutzfeld-Jacob)
- Track 12-6Fragile X syndrome
- Track 12-7Myotonic dystrophy
- Track 12-8Spinobulbar Muscle Dystrophy
- Track 13-1Stroke and ischemia
- Track 13-2Brain lesions
- Track 13-3Epilepsy
- Track 13-4Chronic pain
- Track 13-5Sleep disorders
- Track 13-6Movement disorders (Dystonia; tremor)
- Track 14-1Schizophrenia
- Track 14-2Microglia are the phagocytes of macrophage lineage
- Track 14-3Etiology of Schizophrenia
- Track 14-4Maternal infection and Autism Spectrum Disorders (ASDs)
- Track 14-5Inflammatory cytokines as a mediator
- Track 14-6Glucocorticoids as a mediator
- Track 14-7Macrophage migration in inflamed lesions
- Track 14-8Psychosis
- Track 14-9Tourette Syndrome
- Track 15-1Epidemiology of Diseases
- Track 15-2Pathogenesis
- Track 15-3Therapy of Neurological Infectious disease
- Track 15-4Multiple Sclerosis
- Track 15-5Leukoencephalopathies
- Track 15-6Transverse Myelitis
- Track 15-7Chronic Demyelinating Polyneuropathy
- Track 15-8Myasthenia Gravis
- Track 15-9CNS Autoimmunity
- Track 15-10Chronic Fatigue Syndrome
- Track 15-11Fibromyalgia
- Track 16-1Bacterial Infections
- Track 16-2Guillain-Barre Syndrome
- Track 16-3Amyloid Neuropathy
- Track 16-4Inherited Neurologic disorders
- Track 16-5Nerve damage
- Track 16-6Mononeuropathy or Plexopathy
- Track 16-7Carpal Tunnel Syndrome
- Track 16-8Genetic Neuropathies
- Track 16-9Diagonosis of Chronic Immune-Mediated Polyneuropathies
- Track 16-10Vasculitic Neuropathy
- Track 16-11Peripheral Neuropathy
- Track 17-1Neurogenesis
- Track 17-2Astrocytes
- Track 17-3Dendritic cells
- Track 17-4Neuropathic pain
- Track 17-5Peripheral nerve injury
- Track 17-6Neurotransmitters, Neuropeptides and Neurohormones
- Track 17-7Circadian Rhythms and Sleep Research
- Track 17-8Post-Synaptic channels
- Track 17-9Neuro-imaging
- Track 17-10Transverse Myelitis
- Track 18-1Cytokines
- Track 18-2Hypothalamic-pituitary-adrenal (HPA) axis
- Track 18-3Auto-immune T-cells
- Track 18-4Opioids-cellular signaling
- Track 18-5Corticosteroids-Hormonal signaling
- Track 18-6Innate immune response
- Track 18-7Immunosurveillance in the CNS
- Track 18-8CNS parenchyma
- Track 18-9Pathogen infiltration and endogenous disease agents
- Track 18-10CB2 drugs
- Track 18-11Immune cell trafficking
- Track 18-12Neuroimmune cross-talk